期刊文献+

复方六月雪对HepG2.2.15细胞HBV DNA的抑制作用 被引量:16

The inhibitory effect of Compound Liuyuexue (复方六月雪) on HBV DNA in the HepG2.2.15 cells
在线阅读 下载PDF
导出
摘要 目的:观察复方六月雪体外抗乙型肝炎病毒(HBV)的作用。方法:采用MTT法检测复方六月雪对HepG2.2.15细胞的半数毒性浓度(TC50)和最大无毒浓度(TC0);在最大无毒浓度(TC0)基础上观察不同浓度药物作用于HepG2.2.15细胞,分别在第72h和144h收集细胞培养上清液,采用实时荧光定量PCR法检测上清液HBV DNA的含量。结果:TC50为3.070mg/ml,TC0为0.945mg/ml,复方六月雪对HepG2.2.15细胞毒性较低。无毒浓度下的复方六月雪在HepG2.2.15细胞培养中可有效地抑制细胞HBVDNA的复制。结论:CLYX在体外有显著的抗HBV的作用,且毒性较低。 Objective: To study the inhibitory effect of traditional Chinese medicine Compound Liuyuexue (CLYX) on HBV in vitro. Methods : The TC50 and TC0 of CLYX to the HepG2.2.15 cells were determined by MTT assay. At non-cellulotoxic concentration, the different concentrations of CLYX were added respectively to HepG2.2.15 cells, which were incubated subsequently. At 72h and 144h after the treatment with drugs, the culture media were collected for determining the quantity of HBV DNA detected by real time fluorescence quantitative PCR (FQ-PCR). Results :TCso =3. 070mg/ml, TC0 =0. 945mg/ml. CLYX had little cellulotoxicity. CLYX at the largest non-cellulotoxic concentration could decrease the HBV DNA level in HepG2.2.15 cell. Conclusion: CLYX can inhibit significantly HBV in vitro, and is a lower toxic drug.
出处 《中药药理与临床》 CAS CSCD 北大核心 2007年第1期59-61,共3页 Pharmacology and Clinics of Chinese Materia Medica
基金 广西科学研究与技术开发计划项目(桂科攻0322024-5E)
关键词 复方六月雪 抗乙型肝炎病毒 HBV DNA HEPG2.2.15细胞 荧光定量PCR Compound Liuyuexue (复方六月雪) anti-HBV HBV DNA HepG2.2.15 cell FQ-PCR
  • 相关文献

参考文献6

  • 1李江,黄忠仕,蒋伟哲,林军,黄仁彬.复方六月雪颗粒提取工艺研究[J].中国药房,2005,16(1):16-19. 被引量:24
  • 2Sells MA,Chen ML,Acs G.Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.Proc Natl Acad Sci USA,1987 Feb; 84(4):1005~1009.
  • 3Mosmann T.Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assays.J Immunol.Methods.1983 Dec 16; 65(1-2):55~63.
  • 4Sells MA,Zelent AZ,Shvartsman M,et al.Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions.J Virol,1988 Aug; 62(8):2836~2844.
  • 5Lampertico P,Malter JS,Gerber MA.Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics.Hepatology,1991 Mar; 13(3):422~426.
  • 6Brechtbuehl K,Whalley SA,Dusheiko GM,et al.A rapid real-time quantitative polymerase chain reaction for hepatitis B virus.J Virol Methods,2001 Apr; 93(1-2):105~113.

二级参考文献6

共引文献23

同被引文献137

引证文献16

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部